Why the study?
Gene panels fail to detect most large genetic variants, but pangenome-based workflows may augment detection of large variants from targeted sequencing.
Does a pangenome-based workflow improve the detection of large variants in cardiomyopathy gene panel data compared to conventional methods?
Does a pangenome-based workflow improve the detection of large variants in cardiomyopathy gene panel data compared to conventional methods?
A pangenome-based workflow significantly improves the precision and recall of detecting large genetic variants from targeted short-read sequencing in cardiomyopathy patients compared to conventional tools.
Gene panels represent a widely used strategy for genetic testing in a vast range of Mendelian disorders. While this approach aids reliable bioinformatic detection of short coding variants, it fails to detect most larger variants. Recent studies have recommended the adoption of pangenomes to augment detection of large variants from targeted sequencing, potentially providing diagnostic laboratories with the possibility to streamline diagnostic work-ups and reduce costs. Here, we analyze a large-scale cohort comprising 1,952 cardiomyopathy cases and 1,805 technically matched controls and show that a pangenome-based workflow, GRAF, conjugates higher precision and recall (F1 score 0.86) compared with conventional orthogonal methods (F1 0-0.57) in detecting potentially pathogenic ≥20bp variants from short-read panel data. Our results indicate that pangenome-based workflows aid precise and cost-effective detection of large variants from targeted sequencing data in the clinical context. This will be particularly relevant for conditions in which these variants explain a high proportion of the disease burden.
No takes yet. Share an insight, caveat, or question.
Mazzarotto et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: